Prediction of corticosteroid responsiveness based on fibroblast-specific protein 1 (FSP1) in patients with IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 23, Issue 10, 2008, Pages 3152-3159

  Harada, Koji ^a   Akai, Yasuhiro ^a   Yamaguchi, Yukinari ^a   Kimura, Kuniko ^a   Nishitani, Yoshiharu ^a   Nakatani, Kimihiko ^a   Iwano, Masayuki ^a   Saito, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Corticosteroid; FSP1; IgA nephropathy; Responsiveness

Indexed keywords

CALVASCULIN; CORTICOSTEROID; STEROID;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CATARACT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; CELL COUNT; FEMALE; FIBROBLASTS; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; KIDNEY; MALE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 52449124481     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn240     Document Type: Article

References (28)

1. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237
2. Koyama A, Igarashi M, Kobayashi M and Members and Co-workers of the Research Group on Progressive Renal Disease. Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 1997; 29: 526-532
3. Alamartine E, Sabatier JC, Guerin C et al. Prognostic factors in mesangial IgA glomerulonephritis: an extensive study with univariate and multivariate analysis. Am J Kidney Dis 1991; 18: 12-19
4. Research Group on Progressive Chronic Renal Disease. Nationwide and long-term survey of primary glomerulonephritis in Japan as observed in 1,850 biopsied cases. Nephron 1999; 82: 205-213
5. Emancipator S, Gallo G, Lamm M. IgA nephropathy: perspectives on pathogenesis and classification. Clin Nephrol 1985; 24: 161-179
6. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237
7. Vleming LJ, de Fijter JW, Westendorp RGJ et al. Histomorphometric correlates of renal failure in IgA nephropathy. Clin Nephrol 1998; 49: 337-344
8. Haas M. Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842
9. Katafuchi R, Oh Y, Hori K et al. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol 1994; 41: 191-198
10. D'Amico G, Minetti L, Ponticelli C et al. Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986; 59: 363-378
11. Kincaid-Smith P, Nicholls K. Mesangial IgA nephropathy. Am J Kidney Dis 1983; 3: 90-102
12. Daniel L, Saingra Y, Giorgi R et al. Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2000; 35: 13-20
13. Bohle A, Strutz F, Muller GA. On the pathogenesis of chronic renal failure in primary glomerulopathies: a view from the interstitium. Exp Nephrol 1994; 2: 205-210
14. Kobayashi Y, Hiki Y, Kokubo T et al. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. Nephron 1996; 72: 237-242
15. Pozzi C, Bolasco PG, Fogazzi GB et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 1999; 353: 883-887
16. Pozzi C, Andrulli S, Del Vecchio L et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol 2004; 15: 157-163
17. Moriyama T, Honda K, Nitta K et al. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol 2004; 8: 237-242
18. Tomino Y, Sakai H. Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease. Clinical guidelines for immunoglobulin A(IgA) nephropathy in Japan, second version. Clin Exp Nephrol 2003; 7: 93-97
19. Tomiyoshi Y, Sakemi T, Ikeda Y et al. Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy. Intern Med 2001; 40: 862-866
20. Tamura S, Ueki K, Ideura H et al. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function. Clin Nephrol 2001; 55: 192-195
21. Moriyama T, Honda K, Nitta K et al. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Clin Exp Nephrol 2004; 8: 237-242
22. Nishitani Y, Iwano M, Yamaguchi Y et al. Fibroblast-specific protein 1 is a specific prognostic marker for renal survival in patients with IgAN. Kidney Int 2005; 68: 1078-1085
23. Ballardie FW, Roberts IS. Controlled prospective trial of prednisolone and cytotoxics in progressive IgA nephropathy. J Am Soc Nephrol 2002; 13: 142-148
24. Katafuchi R, Oh Y, Hori K et al. An important role of glomerular segmental lesions on progression of IgA nephropathy: a multivariate analysis. Clin Nephrol 1994; 41: 191-198
25. Strutz F, Okada H, Lo CW et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405
26. Iwano M, Fischer A, Okada H et al. Conditional abatement of tissue fibrosis using nucleoside analogs to selectively corrupt DNA replication in transgenic fibroblasts. Mol Ther 2001; 3: 149-159
27. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 2004; 13: 279-284
28. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350